215 related articles for article (PubMed ID: 22237625)
21. A novel function of HPV16-E6/E7 in epithelial-mesenchymal transition.
Jung YS; Kato I; Kim HR
Biochem Biophys Res Commun; 2013 Jun; 435(3):339-44. PubMed ID: 23628416
[TBL] [Abstract][Full Text] [Related]
22. Loss of Dependence on Continued Expression of the Human Papillomavirus 16 E7 Oncogene in Cervical Cancers and Precancerous Lesions Arising in Fanconi Anemia Pathway-Deficient Mice.
Park S; Park JW; Pitot HC; Lambert PF
mBio; 2016 May; 7(3):. PubMed ID: 27190216
[TBL] [Abstract][Full Text] [Related]
23. Antibodies against oncoproteins E6 and E7 of human papillomavirus types 16 and 18 in patients with head-and-neck squamous-cell carcinoma.
Zumbach K; Hoffmann M; Kahn T; Bosch F; Gottschlich S; Görögh T; Rudert H; Pawlita M
Int J Cancer; 2000 Mar; 85(6):815-8. PubMed ID: 10709102
[TBL] [Abstract][Full Text] [Related]
24. Gene silencing with siRNA targeting E6/E7 as a therapeutic intervention against head and neck cancer-containing HPV16 cell lines.
Adhim Z; Otsuki N; Kitamoto J; Morishita N; Kawabata M; Shirakawa T; Nibu K
Acta Otolaryngol; 2013 Jul; 133(7):761-71. PubMed ID: 23638950
[TBL] [Abstract][Full Text] [Related]
25. Squamous epithelial hyperplasia and carcinoma in mice transgenic for the human papillomavirus type 16 E7 oncogene.
Herber R; Liem A; Pitot H; Lambert PF
J Virol; 1996 Mar; 70(3):1873-81. PubMed ID: 8627712
[TBL] [Abstract][Full Text] [Related]
26. SLC7A11 as a biomarker and therapeutic target in HPV-positive head and neck Squamous Cell Carcinoma.
Hémon A; Louandre C; Lailler C; Godin C; Bottelin M; Morel V; François C; Galmiche A; Saidak Z
Biochem Biophys Res Commun; 2020 Dec; 533(4):1083-1087. PubMed ID: 33019976
[TBL] [Abstract][Full Text] [Related]
27. Differential anticancer activities of arsenic trioxide on head and neck cancer cells with different human papillomavirus status.
Du S; Liu K; Gao P; Li Z; Zheng J
Life Sci; 2018 Nov; 212():182-193. PubMed ID: 30243648
[TBL] [Abstract][Full Text] [Related]
28. Human papillomavirus type 16 in head and neck carcinogenesis.
Chen R; Aaltonen LM; Vaheri A
Rev Med Virol; 2005; 15(6):351-63. PubMed ID: 15942978
[TBL] [Abstract][Full Text] [Related]
29. Detection of transcriptionally active high-risk HPV in patients with head and neck squamous cell carcinoma as visualized by a novel E6/E7 mRNA in situ hybridization method.
Bishop JA; Ma XJ; Wang H; Luo Y; Illei PB; Begum S; Taube JM; Koch WM; Westra WH
Am J Surg Pathol; 2012 Dec; 36(12):1874-82. PubMed ID: 23060353
[TBL] [Abstract][Full Text] [Related]
30. Human papillomavirus type 16 E6 and E7 genotypes in head-and-neck carcinomas.
Hoffmann M; Lohrey C; Hunziker A; Kahn T; Schwarz E
Oral Oncol; 2004 May; 40(5):520-4. PubMed ID: 15006625
[TBL] [Abstract][Full Text] [Related]
31. Biological basis for increased sensitivity to radiation therapy in HPV-positive head and neck cancers.
Bol V; Grégoire V
Biomed Res Int; 2014; 2014():696028. PubMed ID: 24804233
[TBL] [Abstract][Full Text] [Related]
32. Genome-wide DNA copy number alterations in head and neck squamous cell carcinomas with or without oncogene-expressing human papillomavirus.
Smeets SJ; Braakhuis BJ; Abbas S; Snijders PJ; Ylstra B; van de Wiel MA; Meijer GA; Leemans CR; Brakenhoff RH
Oncogene; 2006 Apr; 25(17):2558-64. PubMed ID: 16314836
[TBL] [Abstract][Full Text] [Related]
33. Detection of human papillomavirus type 16 in oropharyngeal squamous cell carcinoma using droplet digital polymerase chain reaction.
Biron VL; Kostiuk M; Isaac A; Puttagunta L; O'Connell DA; Harris J; Côté DW; Seikaly H
Cancer; 2016 May; 122(10):1544-51. PubMed ID: 26989832
[TBL] [Abstract][Full Text] [Related]
34. HPV16 E6 and E7 proteins induce a chronic oxidative stress response via NOX2 that causes genomic instability and increased susceptibility to DNA damage in head and neck cancer cells.
Marullo R; Werner E; Zhang H; Chen GZ; Shin DM; Doetsch PW
Carcinogenesis; 2015 Nov; 36(11):1397-406. PubMed ID: 26354779
[TBL] [Abstract][Full Text] [Related]
35. The relative ability of human papillomavirus type 6 and human papillomavirus type 16 E7 proteins to transactivate E2F-responsive elements is promoter- and cell-dependent.
Armstrong DJ; Roman A
Virology; 1997 Dec; 239(1):238-46. PubMed ID: 9426463
[TBL] [Abstract][Full Text] [Related]
36. Identifying predictors of HPV-related head and neck squamous cell carcinoma progression and survival through patient-derived models.
Facompre ND; Rajagopalan P; Sahu V; Pearson AT; Montone KT; James CD; Gleber-Netto FO; Weinstein GS; Jalaly J; Lin A; Rustgi AK; Nakagawa H; Califano JA; Pickering CR; White EA; Windle BE; Morgan IM; Cohen RB; Gimotty PA; Basu D
Int J Cancer; 2020 Dec; 147(11):3236-3249. PubMed ID: 32478869
[TBL] [Abstract][Full Text] [Related]
37. TRAF3/CYLD mutations identify a distinct subset of human papillomavirus-associated head and neck squamous cell carcinoma.
Hajek M; Sewell A; Kaech S; Burtness B; Yarbrough WG; Issaeva N
Cancer; 2017 May; 123(10):1778-1790. PubMed ID: 28295222
[TBL] [Abstract][Full Text] [Related]
38. Low- and high-risk human papillomavirus E7 proteins regulate p130 differently.
Barrow-Laing L; Chen W; Roman A
Virology; 2010 May; 400(2):233-9. PubMed ID: 20189212
[TBL] [Abstract][Full Text] [Related]
39. High expression of NFX1-123 in HPV positive head and neck squamous cell carcinomas.
Chintala S; Quist KM; Gonzalez-DeWhitt PA; Katzenellenbogen RA
Head Neck; 2022 Jan; 44(1):177-188. PubMed ID: 34693597
[TBL] [Abstract][Full Text] [Related]
40. Biomarkers of HPV in head and neck squamous cell carcinoma.
Liang C; Marsit CJ; McClean MD; Nelson HH; Christensen BC; Haddad RI; Clark JR; Wein RO; Grillone GA; Houseman EA; Halec G; Waterboer T; Pawlita M; Krane JF; Kelsey KT
Cancer Res; 2012 Oct; 72(19):5004-13. PubMed ID: 22991304
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
